Trademark Search in Canada

KANGPU

View On IC.GC.CA

REGISTERED

on 15 Jan 2020

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

KANGPU BIOPHARMACEUTICALS LTD.

Room 818, 780 Cailun Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai201203

Serial Number

1806258 filed on 25^th Oct 2016

Registration Number

TMA1069555 registered on 15^th Jan 2020

Registration expiry Date

15^th Jan 2030

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

M5A0P6

KANGPU

Trademark usage description

medicines for human purposes, namely, medicines for the treatment of cancer, autoimmune diseases and inflammatory diseases, namely, inflammatory bowel Read More

Classification Information

Class [005]
Medicines for human purposes, namely, medicines for the treatment of cancer, autoimmune diseases and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; biochemical drug, namely, biochemical preparations for medical purposes; medicinal drinks, namely, electrolyte drinks for medical purposes; biological preparations for medical purposes, namely, medical preparations for the treatment of cancer, autoimmune diseases and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, autoimmune disease and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; active pharmaceutical ingredient, namely, chemicals for use as active ingredients in the manufacture of pharmaceutical preparations; traditional Chinese medicines, namely, herbal supplements for general health and well-being, for use in oncology, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, and for the treatment of autoimmune diseases; diagnostic preparations for clinical laboratory use, diagnostic preparations for medical laboratory use, diagnostic reagents for medical diagnostic use; drugs for medical purposes, namely, drugs in finished dosage forms, namely, tablets, capsules, and pills for the treatment of cancer, autoimmune disease and inflammation-related disease, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; dietetic substances consisting of vitamins, minerals, amino acids and trace elements

Classification kind code

Class [035]
Demonstration of goods, namely, sales demonstration for others; advertising agency services; business management assistance; organization of exhibitions of pharmaceutical goods and medical services for commercial or advertising purposes; provision of an on-line marketplace for buyers and sellers of goods and services; import-export agency services; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies, wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale services for pharmaceuticals; retail and wholesale services for pharmaceutical preparations

Classification kind code

Class [042]
Research and development of new products for others; technical research, namely, research and development of vaccines and medicines; chemical research; chemistry services, namely, professional consulting services and advice about medicinal chemistry; bacteriological research; biological research, namely, biochemical research; clinical trials; material testing

Classification kind code

Mark Details

Serial Number

1806258

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 87 on 24^th May 2018	Rep for Service Changed
Submitted for opposition 48 on 24^th May 2018	Agent Changed
Submitted for opposition 87 on 29^th Mar 2018	Rep for Service Changed
Submitted for opposition 48 on 29^th Mar 2018	Agent Changed
Submitted for opposition 12 on 5^th Dec 2017	Extension of Time
Submitted for opposition 22 on 26^th May 2017	Search Recorded
Submitted for opposition 20 on 26^th May 2017	Examiner's First Report
Submitted for opposition 31 on 27^th Oct 2016	Formalized
Submitted for opposition 1 on 26^th Oct 2016	Created
Submitted for opposition 30 on 25^th Oct 2016	Filed